BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27492617)

  • 21. A Novel Coding Variant in SLC39A8 Is Associated With Adolescent Idiopathic Scoliosis in Chinese Han Population.
    Xu L; Wang Y; Wu Z; Dai Z; Liu Z; Qiu Y; Cheng JC; Zhu Z
    Spine (Phila Pa 1976); 2020 Feb; 45(4):226-233. PubMed ID: 31513097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.
    Villani AC; Lemire M; Louis E; Silverberg MS; Collette C; Fortin G; Nimmo ER; Renaud Y; Brunet S; Libioulle C; Belaiche J; Bitton A; Gaudet D; Cohen A; Langelier D; Rioux JD; Arnott ID; Wild GE; Rutgeerts P; Satsangi J; Vermeire S; Hudson TJ; Franchimont D
    PLoS One; 2009 Sep; 4(9):e7154. PubMed ID: 19784369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases.
    Borren NZ; Conway G; Garber JJ; Khalili H; Budree S; Mallick H; Yajnik V; Xavier RJ; Ananthakrishnan AN
    J Crohns Colitis; 2018 Apr; 12(5):525-531. PubMed ID: 29145572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
    J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome.
    Jacobs JP; Goudarzi M; Lagishetty V; Li D; Mak T; Tong M; Ruegger P; Haritunians T; Landers C; Fleshner P; Vasiliauskas E; Ippoliti A; Melmed G; Shih D; Targan S; Borneman J; Fornace AJ; McGovern DPB; Braun J
    Genome Med; 2022 Aug; 14(1):91. PubMed ID: 35971134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of NOD2 Variants on Fecal Microbiota in Crohn's Disease and Controls Without Gastrointestinal Disease.
    Kennedy NA; Lamb CA; Berry SH; Walker AW; Mansfield J; Parkes M; Simpkins R; Tremelling M; Nutland S; ; Parkhill J; Probert C; Hold GL; Lees CW
    Inflamm Bowel Dis; 2018 Feb; 24(3):583-592. PubMed ID: 29462388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.
    Anderson CA; Massey DC; Barrett JC; Prescott NJ; Tremelling M; Fisher SA; Gwilliam R; Jacob J; Nimmo ER; Drummond H; Lees CW; Onnie CM; Hanson C; Blaszczyk K; Ravindrarajah R; Hunt S; Varma D; Hammond N; Lewis G; Attlesey H; Watkins N; Ouwehand W; Strachan D; McArdle W; Lewis CM; ; Lobo A; Sanderson J; Jewell DP; Deloukas P; Mansfield JC; Mathew CG; Satsangi J; Parkes M
    Gastroenterology; 2009 Feb; 136(2):523-9.e3. PubMed ID: 19068216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis.
    Beaudoin M; Goyette P; Boucher G; Lo KS; Rivas MA; Stevens C; Alikashani A; Ladouceur M; Ellinghaus D; Törkvist L; Goel G; Lagacé C; Annese V; Bitton A; Begun J; Brant SR; Bresso F; Cho JH; Duerr RH; Halfvarson J; McGovern DP; Radford-Smith G; Schreiber S; Schumm PL; Sharma Y; Silverberg MS; Weersma RK; ; ; ; D'Amato M; Vermeire S; Franke A; Lettre G; Xavier RJ; Daly MJ; Rioux JD
    PLoS Genet; 2013; 9(9):e1003723. PubMed ID: 24068945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease.
    Silverberg MS; Mirea L; Bull SB; Murphy JE; Steinhart AH; Greenberg GR; McLeod RS; Cohen Z; Wade JA; Siminovitch KA
    Inflamm Bowel Dis; 2003 Jan; 9(1):1-9. PubMed ID: 12656131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease.
    Lin Z; Nelson L; Franke A; Poritz L; Li TY; Wu R; Wang Y; MacNeill C; Thomas NJ; Schreiber S; Koltun WA
    J Crohns Colitis; 2010 Jun; 4(2):132-8. PubMed ID: 21122496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
    Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
    Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects.
    Turpin W; Bedrani L; Espin-Garcia O; Xu W; Silverberg MS; Smith MI; Garay JAR; Lee SH; Guttman DS; Griffiths A; Moayyedi P; Panaccione R; Huynh H; Steinhart HA; Aumais G; Dieleman LA; Turner D; ; Paterson AD; Croitoru K
    BMC Med Genet; 2020 Oct; 21(1):204. PubMed ID: 33059653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota signatures in inflammatory bowel disease.
    Vestergaard MV; Allin KH; Eriksen C; Zakerska-Banaszak O; Arasaradnam RP; Alam MT; Kristiansen K; Brix S; Jess T
    United European Gastroenterol J; 2024 Feb; 12(1):22-33. PubMed ID: 38041519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.
    Huang C; Haritunians T; Okou DT; Cutler DJ; Zwick ME; Taylor KD; Datta LW; Maranville JC; Liu Z; Ellis S; Chopra P; Alexander JS; Baldassano RN; Cross RK; Dassopoulos T; Dhere TA; Duerr RH; Hanson JS; Hou JK; Hussain SZ; Isaacs KL; Kachelries KE; Kader H; Kappelman MD; Katz J; Kellermayer R; Kirschner BS; Kuemmerle JF; Kumar A; Kwon JH; Lazarev M; Mannon P; Moulton DE; Osuntokun BO; Patel A; Rioux JD; Rotter JI; Saeed S; Scherl EJ; Silverberg MS; Silverman A; Targan SR; Valentine JF; Wang MH; Simpson CL; Bridges SL; Kimberly RP; Rich SS; Cho JH; Rienzo AD; Kao LWH; McGovern DPB; Brant SR; Kugathasan S
    Gastroenterology; 2015 Nov; 149(6):1575-1586. PubMed ID: 26278503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The
    Amir Shaghaghi M; Zhouyao H; Tu H; El-Gabalawy H; Crow GH; Levine M; Bernstein CN; Eck P
    Am J Clin Nutr; 2017 Dec; 106(6):1508-1513. PubMed ID: 28971850
    [No Abstract]   [Full Text] [Related]  

  • 38. Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.
    Forbes JD; Van Domselaar G; Bernstein CN
    Inflamm Bowel Dis; 2016 Apr; 22(4):817-25. PubMed ID: 26937623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?
    Hold GL; Smith M; Grange C; Watt ER; El-Omar EM; Mukhopadhya I
    World J Gastroenterol; 2014 Feb; 20(5):1192-210. PubMed ID: 24574795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.